Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts

Zachary T. Resch, Claus Oxvig, Laurie K. Bale, Cheryl A Conover

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Pregnancy-associated plasma protein-A (PAPP-A) is an IGF binding protein protease that appears to function as a post-translational modulator of IGF bioavailability in response to injury. A previous study indicated that the proinflammatory cytokines, TNFα and IL-1β, were potent stimulators of PAPP-A expression in cultured human fibroblasts. In this study, we investigated the intracellular signaling pathways mediating cytokine-stimulated PAPP-A expression. Treatment of human fibroblasts with TNFα and IL-1β (1 nM) had little or no effect on phosphatidylinositol 3-kinase and Erk1/2 activation, pathways commonly associated with proliferation. On the other hand, TNFα and IL-1β induced p38, c-Jun N-terminal kinase (JNK), and nuclear factor (NF)κB activation, pathways more closely related to stress response. An inhibitor of p38 activation (SB203580) had no effect on TNFα-or IL-1β-stimulated PAPP-A expression. The JNK inhibitor, SP600125, had no effect on IL-1β- or TNFα-stimulated PAPP-A mRNA expression. However, SP600125 effectively inhibited IL-1β-induced PAPP-A protein expression. MG-132, a proteasome inhibitor that blocked degradation of the intrinsic NFκB inhibitor, IκB, and thereby prevented NFκB activation, was a potent inhibitor of both TNFα- and IL-1β-stimulated PAPP-A mRNA and protein expression and IGF binding protein-4 protease activity. MG-132 had no effect on JNK phosphorylation or p38 activation, and SB203580 and SP600125 had no effect on IκB degradation, documenting inhibitor specificity. BAY11-7082, another inhibitor of NFκB activation, also inhibited TNFα- and IL-1β-stimulated PAPP-A expression and IGF binding protein-4 protease activity. These data indicate that NFκB activation is the primary mediator of cytokine-stimulated PAPP-A expression in human fibroblasts.

Original languageEnglish (US)
Pages (from-to)885-890
Number of pages6
JournalEndocrinology
Volume147
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

Pregnancy-Associated Plasma Protein-A
Interleukin-1
Fibroblasts
Insulin-Like Growth Factor Binding Protein 4
Peptide Hydrolases
Cytokines
Phosphotransferases
Phosphatidylinositol 3-Kinase
Insulin-Like Growth Factor Binding Proteins
Messenger RNA
Proteasome Inhibitors
JNK Mitogen-Activated Protein Kinases
Biological Availability
Proteins
Phosphorylation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts. / Resch, Zachary T.; Oxvig, Claus; Bale, Laurie K.; Conover, Cheryl A.

In: Endocrinology, Vol. 147, No. 2, 02.2006, p. 885-890.

Research output: Contribution to journalArticle

@article{0edf188008134ce18face2ad445e250b,
title = "Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts",
abstract = "Pregnancy-associated plasma protein-A (PAPP-A) is an IGF binding protein protease that appears to function as a post-translational modulator of IGF bioavailability in response to injury. A previous study indicated that the proinflammatory cytokines, TNFα and IL-1β, were potent stimulators of PAPP-A expression in cultured human fibroblasts. In this study, we investigated the intracellular signaling pathways mediating cytokine-stimulated PAPP-A expression. Treatment of human fibroblasts with TNFα and IL-1β (1 nM) had little or no effect on phosphatidylinositol 3-kinase and Erk1/2 activation, pathways commonly associated with proliferation. On the other hand, TNFα and IL-1β induced p38, c-Jun N-terminal kinase (JNK), and nuclear factor (NF)κB activation, pathways more closely related to stress response. An inhibitor of p38 activation (SB203580) had no effect on TNFα-or IL-1β-stimulated PAPP-A expression. The JNK inhibitor, SP600125, had no effect on IL-1β- or TNFα-stimulated PAPP-A mRNA expression. However, SP600125 effectively inhibited IL-1β-induced PAPP-A protein expression. MG-132, a proteasome inhibitor that blocked degradation of the intrinsic NFκB inhibitor, IκB, and thereby prevented NFκB activation, was a potent inhibitor of both TNFα- and IL-1β-stimulated PAPP-A mRNA and protein expression and IGF binding protein-4 protease activity. MG-132 had no effect on JNK phosphorylation or p38 activation, and SB203580 and SP600125 had no effect on IκB degradation, documenting inhibitor specificity. BAY11-7082, another inhibitor of NFκB activation, also inhibited TNFα- and IL-1β-stimulated PAPP-A expression and IGF binding protein-4 protease activity. These data indicate that NFκB activation is the primary mediator of cytokine-stimulated PAPP-A expression in human fibroblasts.",
author = "Resch, {Zachary T.} and Claus Oxvig and Bale, {Laurie K.} and Conover, {Cheryl A}",
year = "2006",
month = "2",
doi = "10.1210/en.2005-0908",
language = "English (US)",
volume = "147",
pages = "885--890",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts

AU - Resch, Zachary T.

AU - Oxvig, Claus

AU - Bale, Laurie K.

AU - Conover, Cheryl A

PY - 2006/2

Y1 - 2006/2

N2 - Pregnancy-associated plasma protein-A (PAPP-A) is an IGF binding protein protease that appears to function as a post-translational modulator of IGF bioavailability in response to injury. A previous study indicated that the proinflammatory cytokines, TNFα and IL-1β, were potent stimulators of PAPP-A expression in cultured human fibroblasts. In this study, we investigated the intracellular signaling pathways mediating cytokine-stimulated PAPP-A expression. Treatment of human fibroblasts with TNFα and IL-1β (1 nM) had little or no effect on phosphatidylinositol 3-kinase and Erk1/2 activation, pathways commonly associated with proliferation. On the other hand, TNFα and IL-1β induced p38, c-Jun N-terminal kinase (JNK), and nuclear factor (NF)κB activation, pathways more closely related to stress response. An inhibitor of p38 activation (SB203580) had no effect on TNFα-or IL-1β-stimulated PAPP-A expression. The JNK inhibitor, SP600125, had no effect on IL-1β- or TNFα-stimulated PAPP-A mRNA expression. However, SP600125 effectively inhibited IL-1β-induced PAPP-A protein expression. MG-132, a proteasome inhibitor that blocked degradation of the intrinsic NFκB inhibitor, IκB, and thereby prevented NFκB activation, was a potent inhibitor of both TNFα- and IL-1β-stimulated PAPP-A mRNA and protein expression and IGF binding protein-4 protease activity. MG-132 had no effect on JNK phosphorylation or p38 activation, and SB203580 and SP600125 had no effect on IκB degradation, documenting inhibitor specificity. BAY11-7082, another inhibitor of NFκB activation, also inhibited TNFα- and IL-1β-stimulated PAPP-A expression and IGF binding protein-4 protease activity. These data indicate that NFκB activation is the primary mediator of cytokine-stimulated PAPP-A expression in human fibroblasts.

AB - Pregnancy-associated plasma protein-A (PAPP-A) is an IGF binding protein protease that appears to function as a post-translational modulator of IGF bioavailability in response to injury. A previous study indicated that the proinflammatory cytokines, TNFα and IL-1β, were potent stimulators of PAPP-A expression in cultured human fibroblasts. In this study, we investigated the intracellular signaling pathways mediating cytokine-stimulated PAPP-A expression. Treatment of human fibroblasts with TNFα and IL-1β (1 nM) had little or no effect on phosphatidylinositol 3-kinase and Erk1/2 activation, pathways commonly associated with proliferation. On the other hand, TNFα and IL-1β induced p38, c-Jun N-terminal kinase (JNK), and nuclear factor (NF)κB activation, pathways more closely related to stress response. An inhibitor of p38 activation (SB203580) had no effect on TNFα-or IL-1β-stimulated PAPP-A expression. The JNK inhibitor, SP600125, had no effect on IL-1β- or TNFα-stimulated PAPP-A mRNA expression. However, SP600125 effectively inhibited IL-1β-induced PAPP-A protein expression. MG-132, a proteasome inhibitor that blocked degradation of the intrinsic NFκB inhibitor, IκB, and thereby prevented NFκB activation, was a potent inhibitor of both TNFα- and IL-1β-stimulated PAPP-A mRNA and protein expression and IGF binding protein-4 protease activity. MG-132 had no effect on JNK phosphorylation or p38 activation, and SB203580 and SP600125 had no effect on IκB degradation, documenting inhibitor specificity. BAY11-7082, another inhibitor of NFκB activation, also inhibited TNFα- and IL-1β-stimulated PAPP-A expression and IGF binding protein-4 protease activity. These data indicate that NFκB activation is the primary mediator of cytokine-stimulated PAPP-A expression in human fibroblasts.

UR - http://www.scopus.com/inward/record.url?scp=30944448260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30944448260&partnerID=8YFLogxK

U2 - 10.1210/en.2005-0908

DO - 10.1210/en.2005-0908

M3 - Article

VL - 147

SP - 885

EP - 890

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -